(Q33419936)

26 July 2017

title

Knowing the natural course of biomarkers in AD: longitudinal MRI, CSF and PET data (English)

1 reference

26 July 2017

0 references

Van Der Flier WM

1

1 reference

26 July 2017

Scheltens P

series ordinal

2

1 reference

26 July 2017

publication date

1 April 2009

1 reference

The Journal of Nutrition, Health and Aging

26 July 2017

published in

1 reference

26 July 2017

volume

13

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

353-355

1 reference

Memory and MRI-based hippocampal volumes in aging and AD.

26 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12603-009-0041-X

Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12603-009-0041-X

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12603-009-0041-X

Longitudinal changes of CSF biomarkers in memory clinic patients.

21 January 2018

1 reference

12 December 2020

CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.

1 reference

12 December 2020

Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease

1 reference

12 December 2020

PET of brain amyloid and tau in mild cognitive impairment.

1 reference

12 December 2020

Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly

1 reference

12 December 2020

CSF markers for incipient Alzheimer's disease

1 reference

12 December 2020

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

12 December 2020

Longitudinal stability of CSF biomarkers in Alzheimer's disease.

1 reference

12 December 2020

Usefulness of Longitudinal Measurements of -Amyloid1-42 in Cerebrospinal Fluid of Patients with Various Cognitive and Neurologic Disorders

1 reference

12 December 2020

Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.

1 reference

12 December 2020

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

12 December 2020

Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients

1 reference

12 December 2020

Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurements.

1 reference

12 December 2020

Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.

1 reference

12 December 2020

Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study

1 reference

12 December 2020

Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study

1 reference

12 December 2020

Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion

1 reference

12 December 2020

Increasing CSF phospho-tau levels during cognitive decline and progression to dementia

1 reference

12 December 2020

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.

1 reference

12 December 2020

10.1007/S12603-009-0041-X

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1052340497

0 references

Fatcat ID

release_h3k4obyf6nbqngfka74ntj5yz4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h3k4obyf6nbqngfka74ntj5yz4

24 November 2022

mapped directly with Wikidata item

1 reference